×
About 7,770 results

Cancer Risk and Autism Spectrum Disorder: Is There a Link?
https://www.medscape.com/viewarticle/976345

Jun 29th, 2022 - Individuals with autism spectrum disorder (ASD) may be at higher risk of developing cancer early in life, but this risk seems largely related to the presence of co-occurring birth defects or intellectual disability, according to new findings. Researchers found that people with ASD and birth defects had a twofold higher risk of cancer compared with those without ASD. For individuals with birth d...

Early-Onset Pancreatic Cancer Increased in White and Hispanic Women
https://www.clinicaladvisor.com/home/topics/gastroenterology-information-center/early-onset-pancreatic-cancer-increased-white-hispanic-women/

Jun 28th, 2022 - Between 1995 and 2018, non-Hispanic White and Hispanic women in the United States experienced the greatest increases in early-onset pancreatic cancer (EOPC) incidence, according to study results published in Gastroenterology. Researchers extracted data from the North American Association of Central Cancer Registries (NAACCR) for the years 1995 to 2018. The NAACCR dataset consists of information...

Cancer May Increase Risk of Type 2 Diabetes
https://www.medscape.com/viewarticle/976224

Jun 27th, 2022 - A large Danish study has found that cancer increases the risk of new-onset type 2 diabetes, especially certain types of cancer, most notably pancreatic malignancies. "Our study demonstrates that there is an elevated risk of developing diabetes if a person is affected by lung, pancreatic, breast, brain, urinary tract, or uterine cancers," said Lykke Sylow, PhD, associate professor in the Molecul...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://reference.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using the following patient scenario and corresponding questions. If you have a case you would like to suggest for a future Case Challenge, please conta...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://www.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using the following patient scenario and corresponding questions. If you have a case you would like to suggest for a future Case Challenge, please conta...

Beta Blockers Plus Checkpoint Inhibitor Improve Cancer Control
https://www.medscape.com/viewarticle/975972

Jun 21st, 2022 - The study was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway The use of beta blockers with immune checkpoint blockers is associated with better cancer control among patients with solid tumors, especially those with urothelial carcinoma, who demonstrated improved overall survival as well. Why This Matters The findings in this retrospective analysis...

Fast Five Quiz: COVID-19 Vaccines
https://www.medscape.com/viewarticle/958940

Jun 17th, 2022 - Editor's Note: The information in this quiz is current as of 6/17/2022. For the most recent COVID information, see https://www.medscape.com/resource/coronavirus As of June 2022, there have been 527,211,631 confirmed cases of COVID-19 and 6,289,371 COVID-19–related deaths worldwide according to the World Health Organization (though they recently reported that the actual number of COVID-19–relate...

Patient Factors Linked With Liver Remnant Growth in Staged Hepatectomy
https://www.medscape.com/viewarticle/975730

Jun 17th, 2022 - NEW YORK (Reuters Health) - In patients undergoing staged hepatectomy for liver tumors, a technique that combines portal vein ligation and parenchymal in situ split allows for rapid, enhanced hypertrophy of the future liver remnant, and now researchers say they have identified the variables that most consistently influence remnant growth. These include patients' height, weight, and gender, the ...

Slow Progress, but Many Disparities in Cancer Burden Persist
https://www.medscape.com/viewarticle/975827

Jun 17th, 2022 - Cancer continues to exact a high and disproportionate toll on racial and ethnic minorities and other medically underserved populations in the United States, despite some progress in reducing disparities, according to the American Association for Cancer Research (AACR) Cancer Disparities Progress Report 2022. "We are making progress against disparities across the cancer continuum," Electra Paske...

New Treatment Reduces Risk of Anal Cancer in People With HIV
https://www.medscape.com/viewarticle/975710

Jun 16th, 2022 - It all began with the question, "Has your butt been getting enough attention?" Though that may seem unorthodox, it led researchers to discovering a treatment that may help prevent anal cancer in people with HIV/AIDS. It's still featured on their study's website, with this further explanation: "You get your viral load checked, your T-cell count checked, but what about your anus? Did you know tha...

Venetoclax Combos Improve Progression-Free Survival in CLL
https://www.medscape.com/viewarticle/975652

Jun 15th, 2022 - Use of the targeted therapy combination of venetoclax plus obinutuzumab for fit patients with chronic lymphocytic leukemia (CLL) significantly improved progression-free survival (PFS) at 3 years compared with standard chemoimmunotherapy, new phase 3 data show. Adding the BTK inhibitor ibrutinib to the two-drug combination pushed the 3-year PFS even higher, but the risk of severe adverse events ...

Rapid Review Quiz: New Diagnostic Tests
https://www.medscape.com/viewarticle/975025

Jun 13th, 2022 - Since 2018, the World Health Organization has published a list of essential diagnostic tests to aid countries in prioritizing research and development of new diagnostic tests. This yearly Essential Diagnostics List highlights the need for these tests in a clinical setting and also punctuates the importance of such tools. Are you familiar with the latest clinical information on new diagnostic te...

Severe COVID-19 and Blood Cancer: Plasma Therapy May Help
https://www.medscape.com/viewarticle/975409

Jun 10th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For patients with severe COVID-19 who had an underlying hematologic malignancy or solid cancer, outcomes were significantly better following treatment with plasma from convalescent and vaccinated patients, new research shows. The study demonstrated that "plasma from convalescent or vaccinated in...

A New First-line Regimen for Advanced Hodgkin Lymphoma?
https://www.medscape.com/viewarticle/975410

Jun 10th, 2022 - Patients with advanced classical Hodgkin lymphoma treated with first line brentuximab vedotin (Adcetris) plus chemotherapy showed substantial improvements in overall survival compared with those receiving standard chemotherapy, new research shows. Over a follow-up of 6 years, patients on brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) had a 41% lower risk of death vs ...

Novel Drug Safe, Effective in Relapsing MS: 2-Year Data 
https://www.medscape.com/viewarticle/975313

Jun 9th, 2022 - NATIONAL HARBOR, Maryland — Evobrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor for relapsing multiple sclerosis (RMS), is relatively safe and effective over the long-term, new research suggests. Results from the longest follow-up of any BTK inhibitor drug for MS to-date show efficacy over 2½ years in slowing neurodegeneration in the disease. In addition, "extended experien...

High Risk for Persistent Opioid Use in Young People With Sarcoma
https://www.medscape.com/viewarticle/975220

Jun 8th, 2022 - Young people with sarcoma may be at heightened risk for long-term opioid use following their cancer treatment. In a nationally representative cohort of adolescents and young adults with sarcoma, nearly two thirds took opioids during treatment, and almost one quarter of those patients continued to use opioids after treatment ended. "As a clinician, the finding that most adolescents and young adu...

International Trial Finds Best Regimen for Ewing Sarcoma
https://www.medscape.com/viewarticle/975065

Jun 5th, 2022 - High-dose ifosfamide has shown superior survival benefit over three other chemotherapy regimens for patients with recurring or refractory primary Ewing sarcoma (RR-ES) in the practice-changing rEECur trial. This international trial is the first randomized head-to-head comparison of commonly used chemotherapy regimens in patients with the rare and deadly disease. The study results are expected t...

Improved Survival in Subset of Advanced Pancreatic Cancer
https://www.medscape.com/viewarticle/975056

Jun 4th, 2022 - An investigational agent has shown promise in a subgroup of patients with advanced pancreatic cancer, offering hope of a clinical advance in a cancer that remains very difficult to treat.  The drug is nimotuzumab, developed as a joint Chinese–Cuban venture, a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), inhibiting tumor cells that overexpress EGFR. When nimotuzu...

Which Malnutrition Criteria to Use in Gynecologic Cancers?
https://www.medscape.com/viewarticle/974995

Jun 3rd, 2022 - Women with gynecologic cancers who meet criteria for malnutrition before surgery face a higher risk for poor postoperative outcomes. However, the value of preoperative malnutrition assessments depends on the definition of malnutrition used as well as the gynecologic cancer type, according to new findings published in Gynecologic Oncology. For ovarian cancer, two definitions of malnutrition — Eu...

Addressing Comorbidities in Multiple Myeloma: Treating People, Not the Disease
https://www.medscape.com/viewarticle/964338

Jun 2nd, 2022 - This transcript has been edited for clarity. Joseph Mikhael, MD: Hello. I'm Dr Joseph Mikhael, and welcome to Medscape InDiscussion on multiple myeloma. Today we're talking about addressing comorbidities in multiple myeloma. I picked this topic because it's so critical in the field of oncology in general, but in particular in multiple myeloma, where over half of our patients are aged 70 years o...